Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference
Rhea-AI Summary
Apogee Therapeutics (NASDAQ: APGE) has announced its upcoming participation in the Jefferies Global Healthcare Conference. The company's management team will engage in a fireside chat scheduled for Thursday, June 5, 2025, at 10:30 a.m. ET. Interested parties can access both live and archived versions of the presentation through the News & Events page in the Investors section of Apogee's website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, APGE gained 3.53%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN FRANCISCO and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 10:30 a.m. E.T.
A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.
About Apogee
Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, including for the treatment of AD, asthma, EoE, COPD and other I&I indications. Apogee’s antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. APG777, the company’s most advanced program, is being initially developed for the treatment of AD, which is the largest and one of the least penetrated I&I markets. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today’s standard of care. For more information, please visit https://apogeetherapeutics.com.
Investor Contact:
Noel Kurdi
VP, Investor Relations
Apogee Therapeutics, Inc.
noel.kurdi@apogeetherapeutics.com
Media Contact:
Dan Budwick
1AB
dan@1abmedia.com
FAQ
When is Apogee Therapeutics (APGE) presenting at the Jefferies Healthcare Conference 2025?
How can I watch Apogee Therapeutics' (APGE) presentation at the Jefferies Conference?
What type of presentation will APGE give at the Jefferies Healthcare Conference?
Where can I find the replay of Apogee Therapeutics' Jefferies Conference presentation?
